Copyright
©2010 Baishideng Publishing Group Co.
World J Gastroenterol. Nov 14, 2010; 16(42): 5334-5341
Published online Nov 14, 2010. doi: 10.3748/wjg.v16.i42.5334
Published online Nov 14, 2010. doi: 10.3748/wjg.v16.i42.5334
Figure 6 Suppression of advanced glycation end-products-stimulated growth by MK615 and apoptosis induction.
A: The percentage inhibition of Glycer-advanced glycation end-products (AGE) by MK615 was significantly higher than those for the control, and Glc-AGE in HuH7 cells. In HepG2 cells, there were no significant differences among the groups. B: Frequency of apoptotic cells of Glycer-AGE by MK615 was significantly higher than those for the control, and Glc-AGE in HuH7 cells. In HepG2 cells, there were no significant differences among the groups. ss: Statistically significant.
- Citation: Sakuraoka Y, Sawada T, Okada T, Shiraki T, Miura Y, Hiraishi K, Ohsawa T, Adachi M, Takino JI, Takeuchi M, Kubota K. MK615 decreases RAGE expression and inhibits TAGE-induced proliferation in hepatocellular carcinoma cells. World J Gastroenterol 2010; 16(42): 5334-5341
- URL: https://www.wjgnet.com/1007-9327/full/v16/i42/5334.htm
- DOI: https://dx.doi.org/10.3748/wjg.v16.i42.5334